We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.

Contraception and GLP-1 Agonist Information
What are GLP-1 agonists?
- These are prescription medicines used in type 2 diabetes or weight management.
Contraception considerations
- If you’re using Tirzepatide: use an additional barrier method (e.g., condoms) on top of the pill for 4 weeks after you start the medication, and again for 4 weeks after any dose increase.
- Non-oral contraceptive methods (coil–implant, injection, patch, ring) are not shown to be affected by GLP-1 agonists.
- If you’re planning pregnancy: GLP-1 agonists should not be used during pregnancy. Effective contraception is vital while on them, and you should stop them for the recommended wash-out period before trying for pregnancy. (E.g., Tirzepatide – 1 month, Semaglutide – 2 months)
What to do next?
- If you’re taking a GLP-1 agonist and using any form of contraception (especially oral), please discuss this with your clinician or practice nurse. We can review your method.